Related references
Note: Only part of the references are listed.Angiogenic factors as diagnostic tests for preeclampsia: a performance comparison between two commercial immunoassays
Samantha J. Benton et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2011)
Threshold of Soluble Fms-Like Tyrosine Kinase 1/Placental Growth Factor Ratio for the Imminent Onset of Preeclampsia
Akihide Ohkuchi et al.
HYPERTENSION (2011)
Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia
Tinnakorn Chaiworapongsa et al.
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2011)
Automated assays for sVEGF R1 and PlGF as an aid in the diagnosis of preterm preeclampsia: a prospective clinical study
Shiraz Sunderji et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2010)
An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia
Stefan Verlohren et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2010)
Prospective Study of Placental Angiogenic Factors and Maternal Vascular Function Before and After Preeclampsia and Gestational Hypertension
Muna Noori et al.
CIRCULATION (2010)
Evaluation of a new and automated electrochemiluminescence immunoassay for plasma sFlt-1 and PlGF levels in women with preeclampsia
Akihide Ohkuchi et al.
HYPERTENSION RESEARCH (2010)
Circulating angiogenic factors determined by electrochemiluminescence immunoassay in relation to the clinical features and laboratory parameters in women with pre-eclampsia
Attila Molvarec et al.
HYPERTENSION RESEARCH (2010)
Soluble fms-Like Tyrosine Kinase 1 (sFlt1), Endoglin and Placental Growth Factor (PlGF) in Preeclampsia among High Risk Pregnancies
Robert W. Powers et al.
PLOS ONE (2010)
A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia
Juan Pedro Kusanovic et al.
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2009)
Maternal plasma soluble fms-like tyrosine kinase-1 and placental growth factor levels as biochemical markers of gestational hypertension for Malaysian mothers
Vishna D. Nadarajah et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2009)
Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia
Antonio De Vivo et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2008)
Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors
Ji Hyae Lim et al.
OBSTETRICS AND GYNECOLOGY (2008)
Effect of Antihypertensive Therapy with Alpha Methyldopa on Levels of Angiogenic Factors in Pregnancies with Hypertensive Disorders
Asma Khalil et al.
PLOS ONE (2008)
Increased sFlt-1 to PIGF ratio in women who subsequently develop Preeclampsia
Shin-Young Kim et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2007)
Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: Relationship to circulating placental growth factor
E Shibata et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Circulating angiogenic factors and the risk of preeclampsia
RJ Levine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Maternal serum sFIt1 concentration is an early and reliable predictive marker of preeclampsia
A Hertig et al.
CLINICAL CHEMISTRY (2004)
Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop
GC McKeeman et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2004)
Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia
JC Livingston et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2000)
Share Paper
